Vikram Thermo India [VIKRAMTH] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Vikram Thermo India Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Vikram Thermo India Ltd. wins in 15 metrics, Sun Pharma Advanced Research Company Ltd. wins in 3 metrics, with 0 ties. Vikram Thermo India Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Vikram Thermo India Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 14.06 -13.65 Vikram Thermo India Ltd.
Price-to-Book Ratio 3.49 -13.55 Vikram Thermo India Ltd.
Debt-to-Equity Ratio 1.59 -1.21 Vikram Thermo India Ltd.
PEG Ratio 1.56 -11.15 Vikram Thermo India Ltd.
EV/EBITDA 9.54 -22.27 Vikram Thermo India Ltd.
Profit Margin (TTM) 27.38% -53.22% Vikram Thermo India Ltd.
Operating Margin (TTM) 42.26% -700.71% Vikram Thermo India Ltd.
EBITDA Margin (TTM) 42.26% N/A N/A
Return on Equity 6.67% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 5.55% -102.08% Vikram Thermo India Ltd.
Free Cash Flow (TTM) $-171.83M $-3.71B Vikram Thermo India Ltd.
Dividend Yield 1.03% N/A N/A
1-Year Return 15.09% 34.88% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 3.85 87.98 Vikram Thermo India Ltd.
Enterprise Value $4.69B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 3.78 95.73 Vikram Thermo India Ltd.
Gross Profit Margin (TTM) 68.12% -59.53% Vikram Thermo India Ltd.
Revenue per Share (TTM) $40 $2 Vikram Thermo India Ltd.
Earnings per Share (Diluted) $10.86 $-8.25 Vikram Thermo India Ltd.
Beta (Stock Volatility) -0.17 0.19 Vikram Thermo India Ltd.

Vikram Thermo India Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

VIKRAMTH
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Vikram Thermo India Ltd.0.42%-0.74%27.11%32.24%17.53%19.64%
Sun Pharma Advanced Research Company Ltd.2.36%12.49%39.95%100.62%67.89%69.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Vikram Thermo India Ltd.15.09%128.85%10.31%159.92%667.33%667.33%
Sun Pharma Advanced Research Company Ltd.34.88%14.54%-3.55%-20.47%148.26%-23.02%

Performance & Financial Health Analysis: Vikram Thermo India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricVIKRAMTHSPARC
Market Information
Market Cap i₹4.79B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i7,3582,401,062
90 Day Avg. Volume i7,0132,083,443
Last Close₹193.40₹229.03
52 Week Range₹126.85 - ₹216.50₹108.00 - ₹248.75
% from 52W High-10.67%-7.93%
All-Time High₹311.00 (Apr 25, 2022)₹875.00 (Apr 24, 2006)
% from All-Time High-37.81%-73.83%
Growth Metrics
Quarterly Revenue Growth-0.01%-0.43%
Quarterly Earnings Growth0.09%-0.43%
Financial Health
Profit Margin (TTM) i0.27%-0.53%
Operating Margin (TTM) i0.42%-7.01%
Return on Equity (TTM) i0.07%1.58%
Debt to Equity (MRQ) i1.59-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹43.76₹-10.63
Cash per Share (MRQ)₹3.51₹0.03
Operating Cash Flow (TTM) i₹325.14M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹80.99M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i1.03%N/A
Last 12-Month Dividend i₹1.75N/A

Valuation & Enterprise Metrics Analysis: Vikram Thermo India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricVIKRAMTH (Apr 26, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i14.06-13.65
Forward P/E iN/A2.60
PEG Ratio i1.56-11.15
Price to Sales (TTM) i3.8587.98
Price to Book (MRQ) i3.49-13.55
Market Capitalization
Market Capitalization i₹4.79B₹46.75B
Enterprise Value i₹4.69B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i3.7895.73
Enterprise to EBITDA i9.54-22.27
Risk & Other Metrics
Beta i-0.170.19
Book Value per Share (MRQ) i₹43.76₹-10.63

Financial Statements Comparison: Vikram Thermo India Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVIKRAMTH (2025)SPARC (2025)
Revenue/Sales i1.25B717.66M
Cost of Goods Sold i554.93M1.10B
COGS % of Revenue i44.4%153.2%
Gross Profit i694.42M-381.94M
Gross Margin i55.6%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i433.39M-3.34B
Operating Margin i34.7%-465.5%
EBITDA i462.90M-3.23B
EBITDA Margin i37.1%-450.0%
Pre-Tax Income i441.36M-3.43B
Pre-Tax Income % of Revenue i35.3%-477.6%
Income Tax i103.77M-2.72M
Income Tax % of Revenue i8.3%-0.4%
Net Income (Profit) i80.99M-3.43B
Profit Margin i6.5%-477.3%

Balance Sheet & Liquidity Metrics

MetricVIKRAMTH (2025)SPARC (2025)
Cash & Equivalents i1.62M19.64M
Total Current Assets i627.63M261.97M
Total Current Assets % of Revenue i50.2%36.5%
Total Current Liabilities i200.68M3.74B
Total Current Liabilities % of Revenue i16.1%521.5%
Long-Term Debt i21.88M1.07B
Long-Term Debt % of Revenue i1.8%149.0%
Total Shareholders Equity i1.21B-2.17B
Retained Earnings i806.21M-23.22B
Retained Earnings % of Revenue i64.5%-3,235.0%
Property, Plant & Equipment i27.49M178.02M

Cash Flow Statement Comparison

MetricVIKRAMTH (2025)SPARC (2025)
Operating Cash Flow i325.14M-3.48B
Operating Cash Flow % of Revenue i26.0%-485.5%
Capital Expenditures i-395.52M-97.45M
Free Cash Flow i-171.83M-3.71B
FCF Margin i-13.8%-516.4%
Debt Repayment i-23.32M-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVIKRAMTHSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i31.36M324.52M
Float Shares i9.21M91.32M
% Held by Insiders i69.51%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i30.49%24.48%

Dividend Analysis & Yield Comparison: Vikram Thermo India Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricVIKRAMTHSPARC
Last 12-Month Dividend i₹1.75N/A
Last 12-Month Dividend Yield i1.03%N/A
3-Year Avg Annual Dividend i₹0.75N/A
3-Year Avg Dividend Yield i0.50%N/A
3-Year Total Dividends i₹2.25N/A
Ex-Dividend DateSep 19, 2025N/A